Page 108 - Neuropsychiatric.indd
P. 108

28. Dopheide JA, Gomez S. Chapter 19 Anxiety. In: Tisdale JE et al., eds. Drug-Induced
                   Diseases: Prevention, Detection, and Management. 3rd ed. United States: American

                   Society of Health-System Pharmacists, Inc., 2018.
               29. มาโนช หล่อตระกูล และปราโมทย์ สุคนิชย์. การวินิจฉัยและรักษาผู้ป่วยวิตกกังวล. [accessed 29
                   November 2020]. Available from: https://med.mahidol.ac.th/ramamental/generaldoctor/
                   06052015-1404

               30. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50–55.
               31. Casagrande Tango R. Psychiatric side effects of medications prescribed in internal medicine.
                   Dialogues Clin Neurosci. 2003;5(2):155-65.

               32. Munjal S, Smolin Y. Ciprofloxacin associated exacerbation of anxiety in an elderly patient:
                   a review of anxiogenic potential of fluoroquinolones. J Clin Psychopharmacol. 2017;37(3):
                   370-372.
               33. Kandasamy A, Srinath D. Levofloxacin-induced acute anxiety and insomnia. J Neurosci Rural
                   Pract. 2012;3(2):212-4.

               34. Welty TE. Chapter 10 Seizures. In: Tisdale JE et al., eds. Drug-Induced Diseases: Prevention,
                   Detection, and Management. 3rd ed. United States: American Society of Health-System
                   Pharmacists, Inc., 2018.


                                                                    ั
                        ั
                                                     ั
                                                                              ุ
               35. สถาบนประสาทวิทยา. แนวทางเวชปฏิบติโรคลมชักสาหรบแพทย. กรงเทพมหานคร: บริษัท ธนาเพลส
                                                                          ์
                   จ ากัด, 2559.
               36. Hitchings AW. Drugs that lower the seizure threshold. Adverse Drug Reaction Bulletin 2016:
                   298(1):1151-4.
               37. Chen HY, Albertson TE, Olson KR. Treatment of drug-induced seizures. Br J Clin Pharmacol.
                   2016;81(3):412-9.
               38. Grosset KA, Grosset DG. Prescribed drugs and neurological complications. J Neurol
                   Neurosurg Pshchiatry 2004;75(Suppl 3):iii2-iii8.

               39. Murphy K, Delanty N. Drug-Induced seizures: general principles in assessment,
                   management and prevention. CNS Drugs 2000;14(2):135-46.
               40. Wanleenuwat P,  Suntharampillai N, Iwanowski  P.  Antibiotic-induced  epileptic seizures:
                   mechanisms of action and clinical considerations. Seizure. 2020;81:167-74.

               41. Kastrup EK. eds. Drug facts and comparisons 2017. London: Lippincott Williams & Wilkins
                   Europe. 2017.
               42. Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. The risk of seizures among the
                   carbapenems: a meta-analysis. J Antimicrob Chemother. 2014;69(8):2043-55.

               43. Nakhaee S, Amirabadizadeh A, Brent J, Miri-Moghaddam E, Foadoddini M, Farrokhfall K, et
                   al. Tramadol and the occurrence of seizures: a systematic review and meta-analysis. Crit
                   Rev Toxicol. 2019 Sep;49(8):710-723.
               44. Lexi-drugs  online. Lexicomp,  Inc.; 2021  [accessed  20 February  2021].  Available from:

                   http://online.lexi.com. Subscription required to view.


                                                                                                        87
                                                                                                        87
   103   104   105   106   107   108   109   110   111   112   113